V003-0134 Screening compound: N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide

V003-0134 Screening compound: N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide
V003-0134 Screening compound: N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-0134
N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-0134

Molecular Formula

C29H37N3O4S (C29 H37 N3 O4 S)

Compound Name

N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide

IUPAC name

N-[(5-methylfuran-2-yl)methyl]-N-(2-phenylethyl)-2-{N-[2-(pyrrolidin-1-yl)ethyl]4-methylbenzenesulfonamido}acetamide

SMILES

Cc1ccc(CN(CCc2ccccc2)C(CN(CCN2CCCC2)S(c2ccc(C)cc2)(=O)=O)=O)o1

InChI

InChI=1S/C29H37N3O4S/c1-24-10-14-28(15-11-24)37(34,35)32(21-20-30-17-6-7-18-30)23-29(33)31(22-27-13-12-25(2)36-27)19-16-26-8-4-3-5-9-26/h3-5,8-15H,6-7,16-23H2,1-2H3

InChI Key

GBLSBZRUXKLCGW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19765571

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

523.7

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.535

Distribution Coefficient, logD

3.647

Water Solubility, LogSw

-4.19

Polar Surface Area

58.594

Acid Dissociation Constant (pKa)

21.87

Base Dissociation Constant (pKb)

8.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.40

V003-0134 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

SH2 Library (10483 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with V003-0134 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-0134?
Check Price and Availability of V003-0134, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-0134 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-0134
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-0134
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-0134 available by request